Papers in Cancer Drug Resistance
Page 10 · newest first
- New insights into acquired endocrine resistance of breast cancerCancer Drug Resistance · 2019
- Resistance to ERK1/2 pathway inhibitors; sweet spots, fitness deficits and drug addictionCancer Drug Resistance · 2019
- Role of cellular reprogramming and epigenetic dysregulation in acquired chemoresistance in breast cancerCancer Drug Resistance · 2019
- Enhanced Kat3A/Catenin transcription: a common mechanism of therapeutic resistanceCancer Drug Resistance · 2019
- MicroRNA-126 and epidermal growth factor-like domain 7 predict recurrence in patients with colon cancer treated with neoadjuvant chemotherapyCancer Drug Resistance · 2019
- Drug targets and resistance mechanisms in multiple myelomaCancer Drug Resistance · 2018
- Targeted therapies in cancer: where are we going?Cancer Drug Resistance · 2018
- How to overcome ATP-binding cassette drug efflux transporter-mediated drug resistance?Cancer Drug Resistance · 2018
- Cancer drug resistance: a new perspectiveCancer Drug Resistance · 2018
- Improved potency of F10 relative to 5-fluorouracil in colorectal cancer cells with p53 mutationsCancer Drug Resistance · 2018
- Identification and targeting of CD22ΔE12 as a molecular RNAi target to overcome drug resistance in high-risk B-lineage leukemias and lymphomasCancer Drug Resistance · 2018
- Resistance to epidermal growth factor receptor inhibition in non-small cell lung cancerCancer Drug Resistance · 2018
- Antibody drug conjugate development in gastrointestinal cancers: hopes and hurdles from clinical trialsCancer Drug Resistance · 2018
- Hitting a moving target: inhibition of the nuclear export receptor XPO1/CRM1 as a therapeutic approach in cancerCancer Drug Resistance · 2018
- Wilms’ tumor gene (WT1) is strongly expressed in high-risk subsets of pediatric acute lymphoblastic leukemiaCancer Drug Resistance · 2018
- Sphingolipid metabolism and drug resistance in ovarian cancerCancer Drug Resistance · 2018
- Epigenetics, a key player of immunotherapy resistanceCancer Drug Resistance · 2018
- Glutamine metabolism in cancer therapyCancer Drug Resistance · 2018
- What really matters - response and resistance in cancer therapyCancer Drug Resistance · 2018